I want to say one word to you - Just one word - "plastics"

Transfusion

Volumn 46, Issue 4, 2006, Pages 503-506

  Luban, Naomi ^a   Rais Bahrami, Khodayar ^a   Short, Billie ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCRINE DISRUPTOR; PHTHALIC ACID; PLASTIC;

BLOOD BANK; BLOOD TRANSFUSION; CHEMICAL CARCINOGENESIS; EDITORIAL; ENVIRONMENTAL EXPOSURE; HEMODIALYSIS; HIGH RISK INFANT; HUMAN; HYPEROXIA; LEACHING; NEWBORN INTENSIVE CARE; PREGNANT WOMAN; PREMATURITY; REPRODUCTIVE TOXICITY; TANDEM MASS SPECTROMETRY; TOXICITY TESTING;

BLOOD TRANSFUSION; DIETHYLHEXYL PHTHALATE; HUMANS; PHTHALIC ACIDS; PLASTICIZERS; POLYVINYL CHLORIDE;

EID: 33645292048     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00766.x     Document Type: Editorial

References (30)

1. Jaeger RJ Rubin RJ. Extraction, localization, and metabolism of di-2-ethylhexyl phthalate from PVC plastic medical devices. Environ Health Perspect 1973 3 95 102.
2. Peck CC Albro PW. Toxic potential of the plasticizer Di(2-ethylhexyl) phthalate in the context of its disposition and metabolism in primates and man. Environ Health Perspect 1982 45 11 7.
3. Marcel YL. Determination of di-2-ethylhexyl phthalate levels in human blood plasma and cryoprecipitates. Environ Health Perspect 1973 3 119 21.
4. Safety assessment of Di(2-ethylhexyl)phthalate (DEHP) released from PVC medical devices [monograph on the Internet]. Rockville (MD) Center for Devices and Radiological Health, U.S. Food and Drug Administration 2001. Available from: http://www.fda.gov/cdrh/ost/dehp-pvc.pdf
5. Hill SS Shaw BR Wu AH. The clinical effects of plasticizers, antioxidants, and other contaminants in medical polyvinylchloride tubing during respiratory and non-respiratory exposure. Clin Chim Acta 2001 304 1 8.
6. A blue ribbon panel report: a scientific evaluation of health effects of two plasticizers used in medical devices and toys. New York The American Council on Science and Health. 1999 Jun 22.
7. Tickner J. The use of di-2-ethylhexyl phthalate in PVC medical devices: exposure, toxicity, and alternatives. Lowell (MA) University of Massachusetts Lowell Center for Sustainable Production 1999.
8. Silva MJ Barr DB Reidy JA et al. Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ Health Perspect 2004 112 331 8.
9. Scientific Community on Medicinal Products and Medical Devices. Opinion on medical devices containing DEHP plasticised PVC; Neonates and other groups possibly at risk from DEHP toxicity [monograph on the Internet]. Document SANCO/SCMPMD/2002/0010. Paris European Commission, Health and Consumer Protection Directorate-General. 2002 Sep 26. Available from: http://europa.eu.int/comm/health/ph_risk/committees/scmp/documents/out43_en.pdf
10. Medical Devices Bureau. Therapeutic Products Directorate. Health Products & Foods Branch, Health Canada. DEHP in Medical Devices: An Exposure and Toxicity Assessment [monograph on the Internet]. Ottawa Health Canada 2002 Jan. Available from http://www.hc-sc.gc.ca/dhp-mps/alt_formats/hpfb-dgpsa/pdf/md-im/ sapdehp_rep_gcsdehp_rap_2001-04-26_e.pdf
11. Medical Devices Bureau. Draft position. statement on DEHP in medical devices for stakeholder consultation. Ottawa Health Canada 2003 May 16. Available from: http://www.hc-sc.gc.ca/dhp-mps/md-im/activit/sci-consult/ dehp_position_draft_ebauche_e.html
12. Ministry of Health, Labour and Welfare Official Web Site [homepage on the Internet]. Tokyo Ministry of Health, Labour and Welfare c2003. Available from: http://www.mhlw.go.jp/english/
13. Rubin RJ Ness PM. What price progress? An update on vinyl plastic blood bags. Transfusion 1989 29 358 61.
14. Shea KM American Academy of Pediatrics Committee on Environmental Health. Pediatric exposure and potential toxicity of phthalate plasticizers. Pediatrics 2003 111 6 Pt 1 1467 74.
15. Sjoberg P Bondesson UG Sedin EG Gustafsson JP. Exposure of newborn infants to plasticizers: plasma levels of di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate during exchange transfusion. Transfusion 1985 25 424 8.
16. Rock G Tocchi M Ganz PR Tackaberry ES. Incorporation of plasticizer into red cells during storage. Transfusion 1984 24 493 8.
17. Barry YA Labow RS Rock G et al. Cardiotoxic effects of the plasticizer metabolite mono(2-ethyhexyl)phthalate (MEHP) on human myocardium. Blood 1988 72 1438 9.
18. Karle VA Short BL Martin GR et al. Extracorporeal membrane oxygenation (ECMO) exposes infants to the plasticizer Di(2-ethylhexyl) phthalate (DEHP). Crit Care Med 1997 25 696 703.
19. Silva MJ Malek NA Hodge CC et al. Improved quantitative detection of 11 urinary phthalate metabolites in human urine using liquid chematography- atmospheric pressure chemical ionization tandem mass spectrometry. J Chromatogr B 2003 789 393 404.
20. Kato K Silva MJ Reidy JA et al. Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. Environ Health Perspect 2004 112 327 30.
21. Rais-Bahrami K Nunez S Revenis ME Luban NL Short BL. Follow-up study of adolescents exposed to di(2-ethylhexyl) phthalate (DEHP) as neonates on extracorporeal membrane oxygenation (ECMO) support. Environ Health Perspect 2004 112 1339 40.
22. Calafat AM Needham LL Silva MJ Lambert G. Exposure to di-(2-ethylhexyl) phthalate among premature neonates in a neonatal intensive care unit. Pediatrics 2004 113 e429 34.
23. Green R Hauser S Calafat AM et al. Use of di-(2-ethylhexyl) phthalate in neonatal intensive care unit infants. Environ Health Perspect 2005 113 1222 5.
24. Swan SH Main KM Liu F et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect 2005 113 1056 61.
25. Karimova A Robertson A Cross N et al. A wet-primed extracorporeal membrane oxygenation circuit with hollow-fiber membrane oxygenator maintains adequate function for use during cardiopulmonary resuscitation after 2 weeks on standby. Crit Care Med 2005 33 1572 6.
26. Gray LE Jr. Ostby J Furr J Price M Veeramachaneni DN Parks L. Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. Toxicol Sci 2000 58 350 65.
27. Gray LE Jr. Foster PM. Significance of experimental studies for assessing adverse effects of endocrine-disrupting chemicals. Pure Appl Chem 2003 75 2125 41.
28. National Toxicology Program, Center for the Evaluation of Risks to Human Reproduction. NTP-CERHR Expert Panel Report on Di(2-Ethyhexyl) Phthalate. Alexandria, VA Center for the Evaluation of Risks to Human Reproduction, US Department of Health and Human Services 2000. Available from http://cerhr.niehs.nih.gov/chemicals/dehp/DEHP-final.pdf
29. Meaney MJ. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu Rev Neurosci 2001 24 1161 92.
30. Spector LG Klebanoff MA Feusner JH Georgieff MK Ross JA Childhood cancer following neonatal oxygen supplementation. J Pediatr 2005 147 27 31.